SCHEMBL7202267

SCHEMBL7202267

O=C(O)CCC(=O)c1ccc(-c2ccc(OC(F)(F)C(F)F)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
FFAR1 O14842 1/20 0.55
LMNA P02545 1/20 0.55
RAB9A P51151 1/20 0.55
HIF1A Q16665 1/20 0.55
ALDH1A1 P00352 3/20 0.49
HSD17B10 Q99714 2/20 0.49
TSHR P16473 1/20 0.49
USP5 P45974 1/20 0.45
KMT2A Q03164 2/20 0.45
TRPV1 Q8NER1 1/20 0.45
NR4A2 P43354 1/20 0.45
CYP2C19 P33261 2/20 0.43
HPGD P15428 2/20 0.43
PDE4B Q07343 1/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 1/20 0.43
MMP2 P08253 2/20 0.42
MMP9 P14780 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4142311 0.87 FFAR1 (0.60) CYP1A2SMN1; SMN2FFAR1LMNARAB9A
SCHEMBL4258765 0.82 NR4A2 (0.53) CYP1A2SMN1; SMN2FFAR1LMNARAB9A
SCHEMBL10884944 0.78 SMN1; SMN2 (0.88) CYP1A2SMN1; SMN2FFAR1LMNARAB9A
SCHEMBL2377766 0.77 ALDH1A1 (0.51) RAB9AHIF1AALDH1A1HSD17B10TSHR
SCHEMBL28012437 0.77 TRPV1 (0.54) SMN1; SMN2RAB9AALDH1A1HSD17B10TSHR
SCHEMBL850939 0.76 ALDH1A1 (0.77) ALDH1A1HSD17B10TSHRKMT2ATRPV1
SCHEMBL7857488 0.75 SMN1; SMN2 (0.66) CYP1A2SMN1; SMN2FFAR1LMNARAB9A
SCHEMBL7864057 0.75 PDE4B (0.73) CYP1A2SMN1; SMN2FFAR1LMNARAB9A
SCHEMBL4035963 0.73 ALDH1A1 (0.42) RAB9AALDH1A1HSD17B10TSHRKMT2A
SCHEMBL7864069 0.73 SMN1; SMN2 (0.72) CYP1A2SMN1; SMN2FFAR1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030220517-A1 Method for producing ketocarboxylic acid derivatives BAYER CROPSCIENCE AG (DE) 2003-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220517-A1 Method for producing ketocarboxylic acid derivatives CYP2F1, HK1, FBP1 CYP1A2 377/4885SMN1; SMN2 4111/4885FFAR1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.